Skip to main content

Table 5 Predictors for the incidence of MACCEs in patients with new-onset NSTEMI

From: Serum total bilirubin and long-term prognosis of patients with new-onset non-ST elevation myocardial infarction: a cohort study

Variables Univariate analysis Multivariate analysis
HR 95% HR p value HR 95% CI p value
Female, n (%) 0.533 0.287–0.991 0.047 0.598 0.319–1.121 0.109
Age (years) 1.011 0.987–1.035 0.387    
Hypertension, n (%) 1.774 1.044–3.012 0.034 1.296 0.742–2.261 0.362
Diabetes mellitus, n (%) 2.130 1.259–3.602 0.005 1.800 1.041–3.113 0.035
Current Smoking, n (%) 1.211 0.720–2.036 0.470    
SBP (mmHg) 1.001 0.988–1.014 0.860    
DBP (mmHg) 0.992 0.969–1.015 0.480    
BMI (kg/m2) 0.958 0.892–1.029 0.237    
HDL-C (mmol/L) 0.517 0.190–1.405 0.196    
LDL-C (mmol/L) 0.891 0.685–1.158 0.388    
TC (mmol/L) 0.956 0.777–1.175 0.667    
TG (mmol/l) 1.001 0.937–1.068 0.996    
ApoA1 (g/L) 0.736 0.311–1.741 0.485    
ApoB (g/L) 0.676 0.284–1.610 0.377    
Creatinine (mmol/L) 0.995 0.984–1.006 0.390    
BUN (mmol/l) 0.943 0.818–1.086 0.412    
Uric acid (mmol/L) 0.998 0.996–1.001 0.299    
CK-MB (U/L) 1.001 0.998–1.002 0.674    
Troponin T (μg/L) 1.232 1.057–1.435 0.007 1.172 1.007–1.365 0.040
TBIL tertiles       
 2nd tertile vs 1st tertile 3.653 1.566–8.518 0.003 2.737 1.161–6.450 0.021
 3rd tertile vs 1st tertile 4.555 1.983–10.465 < 0.001 3.272 1.408–7.607 0.006
LVEF (%) 0.986 0.942–1.032 0.542    
LVEDD (mm) 0.990 0.921–1.066 0.797    
Killip class 0.953 0.570–1.595 0.855    
GRACE Score 0.997 0.989–1.006 0.551    
CRUSADE Score 0.996 0.979–1.013 0.635    
SYNTAX tertiles       
 2nd tertile vs 1st tertile 3.40 1.366–8.469 0.009 2.767 1.097–6.980 0.031
 3rd tertile vs 1st tertile 5.214 2.175–12.498 < 0.001 3.165 1.280–7.827 0.013
UPLMT, n (%) 2.932 1.641–5.240 < 0.001 2.042 1.063–3.923 0.032
PCI, n (%) 1.329 0.726–2.435 0.357    
Medications after discharge       
 Aspirin, n (%) 3.097 0.429–22.380 0.263    
 Clopidogrel, n (%) 2.820 0.687–11.586 0.150    
 Statins, n (%) 2.298 0.561–9.423 0.248    
 β-Blockers, n (%) 1.330 0.671–2.633 0.414    
 ACEI/ARB, n (%) 1.119 0.612–2.045 0.715    
 CCB, n (%) 1.111 0.561–2.202 0.762    
  1. Values of p < 0.05 are indicated in bold. All abbreviations are presented in Table 1